Book review: ‘Copyright and Information Privacy: Conflicting Rights in Balance’ from ipkitten.blogspot.com In
‘Copyright and Information Privacy: Conflicting Rights in Balance’, Federica Giovanella takes us through the regulation of file-sharing in the United States, Canada and Italy to examine its impact on the privacy rights of internet ...
Share via E–mail | Twitter | Facebook
Around the IP Blogs! from ipkitten.blogspot.com Our usual web tour, bringing you IP news and perspectives across the spectrum from last week!
First stop on our tour is Norway. Probably a disappointing and shocking one for Marie Schrader to hear (this ... Share via E–mail | Twitter | Facebook
Never too late: if you missed the IPKat last week! from ipkitten.blogspot.com Catch-up with everything IP! Edition 179 of Never Too Late is here to recap last week’s highlights on IPKat (week ending 21 January)
Trade marks
Are we going to see less conventional trade marks ... Share via E–mail | Twitter | Facebook
Amicus Briefs Filed in Mohawk Tribe's Motion to Dismiss IPRs from www.patentdocs.org By Kevin E. Noonan -- In what everyone (including the Patent Trial and Appeal Board) considers an unprecedented administrative action, the PTAB late last year set our an order (Patent Trial and Appeal Board's Order ...
Share via E–mail | Twitter | Facebook
JPO Refused To Register Wordmark “ROMEO GIGLI” Due To Lack Of Consent From Italian Fashion Designer from www.ip-watch.org In a recent decision, the Appeal Board of Japan Patent Office (JPO) refused to register trademark application no. 2015- 100245 for a red-colored word mark “ROMEO GIGLI” in gothic script (see below) designating goods of ...
Share via E–mail | Twitter | Facebook
WHO Antibiotic Resistance Data Shows Worrying Trend; Industry Ready To Help from www.ip-watch.org Today the World Health Organization released its first set of surveillance data on antibiotic resistance. The data shows that resistance to antibiotics is growing among the world's most common bacteria, in both high- and ...
Share via E–mail | Twitter | Facebook
WHO Board Backs Ambitious Work Programme, Sent For Full Membership Approval from www.ip-watch.org The World Health Organization programme of work 2019-2023 is one step closer to being adopted by member states and serving as a guideline for the future vision and mission of the organisation. The Executive Board ...
Share via E–mail | Twitter | Facebook
Royalty rates paid musicians decline for some leading streaming services from ipcloseup.com When it comes to getting paid, the bigger streaming service is not necessarily better for most musicians and song writers. While the revenue and market share have grown for the leading streaming services, some significantly ...
Share via E–mail | Twitter | Facebook
Appointments and Illegal Adjudication: A Second Patent Judge Appointments Crisis from patentlyo.com In 2007, Prof. John Duffy penned a Patently-O essay explaining that Administrative Patent Judges are at least “inferior officers” under the US Constitution (art. II, § 2, cl. 2) — requiring appointment by a Head of Department ...
Share via E–mail | Twitter | Facebook
Patent Infringement Blog from docketreport.blogspot.com The court granted defendant's motion to transfer plaintiff's patent infringement action from the Central District to the Northern District of California for improper venue and rejected plaintiff's argument that 28 U.S ...
Share via E–mail | Twitter | Facebook
Supreme Court Patent Update for January 2018 from patentlyo.com by Dennis Crouch The Supreme Court has heard oral arguments in Oil States and briefing is ramping-up in one additional case, WesternGeco, that focuses on lost profit damages for international activities. A fairly large number ...
Share via E–mail | Twitter | Facebook
European patent loss for Forward Pharma related to MS fumarate drug from ipbiz.blogspot.com SeekingAlpha reports a European patent decision related to the MS drug Tecfidera (relevant ingredient dimethyl fumarate):
The European Patent Office has revoked Forward Pharma A/S's EP 2801355 patent ('355 patent) following challenges from ... Share via E–mail | Twitter | Facebook